BOUDRY, Switzerland. - Wednesday, June 3rd 2015 [ME NewsWire]

New two-year pooled analysis of PALACE trials evaluated effects of OTEZLA on enthesitis and dactylitis in patients with active psoriatic arthritis

Data assessed the impact of investigational compound CC-220 on levels of systemic lupus erythematosus-associated transcription factors

11 featured abstracts underscore the expansion of the Company’s clinical development program in immune disorders

(BUSINESS WIRE)-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that data from 11 abstracts (two oral presentations, six poster presentations and three published in The Abstract Book) evaluating Celgene investigational and marketed products will be presented at the European League Against Rheumatism (EULAR) Annual Congress in Rome, Italy, June 10 – 13, 2015. The data will include the latest research findings on Otezla® (apremi ... Read more »

Industry Leaders to Discuss Future of Mobile at Mobile 360 – Middle East in October

LONDON - Thursday, June 4th 2015 [ME NewsWire]

(BUSINESS WIRE) -- The GSMA has today announced the first speakers to feature in the Mobile 360 Series – Middle East conference taking place in Dubai, 20-21 October 2015. Now in its third year, the event will bring together representatives from the region’s largest operators and other major industry players to discuss the key opportunities and challenges facing the mobile industry in the Middle East and North Africa.

The first speakers confirmed for the event are:

    Ahmad Abdulkarim Julfar, CEO, Etisalat Group and Deputy Chair, GSMA
    Bob Fox, Global Industry Leader – Telecommunications and Media & Entertainment, IBM Global Business Services
    Dilip Rahulan, Executive Chairman and CEO, Pacific Controls
    Alfred ... Read more »